Common Contracts
1 similar Common Stock Sales Agreement contracts
PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(5)Common Stock Sales Agreement • October 11th, 2022
Capricor Therapeutics, Inc. has entered into a Common Stock Sales Agreement, or the Sales Agreement, with H.C. Wainwright & Co. LLC, or Wainwright, relating to the sale of shares of our common stock, par value $0.001 per share, offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $5,000,000 from time to time through Wainwright acting as agent.
